Impaired synaptic development, maintenance, and neuromuscular transmission in LRP4-related myasthenia
Open accessAbstract
IMPORTANCE: Congenital myasthenic syndromes (CMS) are heterogeneous disorders. Defining the phenotypic features, genetic basis, and pathomechanisms of a CMS is relevant to prognosis, genetic counseling, and therapy. OBJECTIVES: To characterize clinical, structural, electrophysiologic, and genetic features of a CMS and to search for optimal therapy. DESIGN, SETTINGS, AND PARTICIPANTS: Two sisters with CMS affecting the limb-girdle muscles were investigated between 2012 and 2014 at an academic medical center by clinical observation, in vitro analysis of neuromuscular transmission, cytochemical and electron microscopy studies of the neuromuscular junction, exome sequencing, expression studies in HEK293 and COS7 cells, and for response to therapy, and they were compared with 15 historical control participants. MAIN OUTCOMES AND MEASURES: We identified the disease gene and mutation, confirmed pathogenicity of the mutation by expression studies, and instituted optimal pharmacotherapy. RESULTS: Quantitative analysis of single EP regions was done for all 15 control participants and microelectrode studies of neuromuscular transmission and α-bgt binding sites per EP was conducted for 13 control participants. Examination of the older sister's intercostal muscle end plates (EPs) showed them to be abnormally small, with attenuated reactivities for the acetylcholine receptor and acetylcholinesterase. Most EPs had poorly differentiated or degenerate junctional folds, and some appeared denuded of nerve terminals. The amplitude of the EP potential (EPP), the miniature EPP, and the quantal content of the EPP were all markedly reduced. Exome sequencing identified a novel homozygous p.Glu1233Ala mutation in low-density lipoprotein receptor-related protein 4 (LRP4), a coreceptor for agrin to activate muscle-specific tyrosine kinase (MuSK), which is required for EP development and maintenance. Expression studies indicate that the mutation compromises the ability of LRP4 to bind to, phosphorylate, and activate MuSK. Treatment with albuterol sulfate improved the patients' symptoms. A previously identified patient harboring 2 heterozygous mutations in LRP4 had structurally abnormal intercostal EPs but no identifiable defect of neuromuscular transmission at these EPs. CONCLUSIONS AND RELEVANCE: We identified a second CMS kinship harboring mutations in LRP4, identified the mechanisms that impair neuromuscular transmission, and mitigated the disease by appropriate therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Lrp4 functions in neuromuscular junction development and in maintaining the adult neuromuscular junction.
“for its role in neuromuscular junction (NMJ) development and in the maintenance of the adult NMJ”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [87]
Anti-Lrp4 and anti-MuSK antibodies contribute to myasthenia gravis.
“the role of anti-Lrp4 and anti-MuSK antibodies in myasthenia gravis [87]”
From ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease (2017) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Transcription Factor ATF2 Regulation by the JNK Signal Transduction Pathway
Gupta, S., Campbell, D., Dérijard, B., & Davis, R. J. (1995) · Science · doi:10.1126/science.7824938 · Cited by 1,440 · see citing works
Lrp4 is a receptor for Agrin and forms a complex with MuSK
Kim, N., Stiegler, A. L., Cameron, T. O., Hallock, P. T., Gomez, A. M., Huang, J. H., Hubbard, S. R., Dustin, M. L., & Burden, S. J. (2008) · Cell · doi:10.1016/j.cell.2008.10.002 · Cited by 676 · see citing works
A quantitative study of end‐plate potentials in isolated human muscle.
Elmqvist, D., & Quastel, D. M. J. (1965) · The Journal of Physiology · doi:10.1113/jphysiol.1965.sp007639 · Cited by 579 · see citing works
LRP4 serves as a coreceptor of Agrin
Zhang, B., Luo, S., Wang, Q., Suzuki, T., Xiong, W. C., & Mei, L. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.006 · Cited by 525 · see citing works
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Leupin, O., Piters, E., Halleux, C. M., Hu, S., Krämer, I., Morvan, F., Bouwmeester, T., Schirle, M., Bueno-Lozano, M., Fuentes, F. J. R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190330 · Cited by 301 · see citing works
Engel, A. G., Lindstrom, J. M., Lambert, E. H., et al. (1977) · Neurology · doi:10.1212/wnl.27.4.307 · Cited by 250 · see citing works
Self-citationMUSK, a new target for mutations causing congenital myasthenic syndrome
Chevessier, F., Faraut, B., Ravel-Chapuis, A., Richard, P., Gaudon, K., Bauché, S., Prioleau, C., Herbst, R., Goillot, E., Ioos, C., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh333 · Cited by 193 · see citing works
The Role of MuSK in Synapse Formation and Neuromuscular DiseasePreprint
Burden, S. J., Yumoto, N., & Zhang, W. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009167 · Cited by 189 · see citing works
Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function
Huzé, C., Bauché, S., Richard, P., Chevessier, F., Goillot, E., Gaudon, K., Ammar, A. B., Chaboud, A., Grosjean, I., Lecuyer, H.-A., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.015 · Cited by 172 · see citing works
Li, Y., Pawlik, B., Elcioglu, N., Aglan, M., Kayserili, H., Yigit, G., Percin, F., Goodman, F., Nürnberg, G., Cenani, A., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.03.004 · Cited by 171 · see citing works
Fambrough, D. M., Engel, A. G., & Rosenberry, T. L. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1078 · Cited by 154 · see citing works
Self-citationWeston, C. A., Yee, B., Hod, E. A., & Prives, J. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.1.205 · Cited by 148 · see citing works
Herrmann, D. N., Horváth, R., Sowden, J. E., Gonzales, M. A., Sánchez-Mejías, A., Guan, Z., Whittaker, R. G., Almodovar, J. L., Lane, M., Bánsági, B., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.08.007 · Cited by 125 · see citing works
Ohkawara, B., Cabrera‐Serrano, M., Nakata, T., Milone, M., Asai, N., Ito, K., Ito, M., Masuda, A., Ito, Y., Engel, A. G., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt578 · Cited by 124 · see citing works
Self-citationAgrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy
Nicole, S., Chaouch, A., Torbergsen, T., Bauché, S., Bruyckere, E. D., Fontenille, M., Horn, M. A., Ghelue, M. V., Løseth, S., Issop, Y., et al. (2014) · Brain · doi:10.1093/brain/awu160 · Cited by 105 · see citing works
Myasthenia Gravis and Myasthenic Disorders
(2012) · Oxford University Press eBooks · doi:10.1093/med/9780199738670.001.0001 · Cited by 104 · see citing works
Mutations in MUSK causing congenital myasthenic syndrome impair MuSK–Dok-7 interaction
Maselli, R. A., Arredondo, J., Cagney, Ó., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq110 · Cited by 101 · see citing works
Maselli, R. A., Fernández, J. M., Arredondo, J., et al. (2011) · Human Genetics · doi:10.1007/s00439-011-1132-4 · Cited by 97 · see citing works
An ATF2‐based luciferase reporter to monitor non‐canonical Wnt signaling in xenopus embryos
Ohkawara, B., & Niehrs, C. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22500 · Cited by 74 · see citing works
Self-citationCongenital myasthenic syndromes: I. Deficiency and short open‐time of the acetylcholine receptor
Engel, A. G., Nagel, A., Walls, T. J., et al. (1993) · Muscle & Nerve · doi:10.1002/mus.880161204 · Cited by 73 · see citing works
Self-citationUchitel, O. D., Engel, A. G., Walls, T. J., et al. (1993) · Muscle & Nerve · doi:10.1002/mus.880161205 · Cited by 73 · see citing works
Self-citationHh, I., & Rg, B. (1968) · PubMed · Cited by 70 · see citing works
REFINEMENT OF THE CLINICAL PHENOTYPE IN MUSK-RELATED CONGENITAL MYASTHENIC SYNDROMES
Mihaylova, V., Salih, M. A., Mukhtar, M., Abuzeid, H., El-Sadig, S., von der Hagen, M., Huebner, A., Nürnberg, G., Abicht, A., Müller, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c3fce9 · Cited by 67 · see citing works
A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia
Ammar, A. B., Soltanzadeh, P., Bauché, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053826 · Cited by 51 · see citing works
The Investigation of Congenital Myasthenic Syndromesa
Engel, A. G. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb22927.x · Cited by 50 · see citing works
Self-citationMaggi, L., Brugnoni, R., Scaioli, V., et al. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7118-5 · Cited by 26 · see citing works
Electrodiagnosis of Myasthenic Disorders
Harper, C. M. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199738670.003.0002 · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [15]Engel AG Engel AG Franzini-Armstrong C Quantitative morphological studies of muscle Myology 1994 2nd ed New York McGraw-Hill 1018 1045
Cited by
Sorted by citations
ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease
Lane-Donovan, C., & Herz, J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.12.001 · Cited by 157 · see citing works
“Lrp4 is more commonly known as the gene defective in Cenani-Lenz syndrome [83–86], and for its role in neuromuscular junction (NMJ) development and in the maintenance of the adult NMJ, which is highlighted clinically by the role of anti-Lrp4 and anti-MuSK antibodies in myasthenia gravis [87].”
Background
- Authors
- Selcen, D., Ohkawara, B., Shen, X.-M., McEvoy, K., Ohno, K., & Engel, A. G.
- Affiliations
- Mayo Clinic (US)
- Nagoya University (JP)
- Corresponding author
- Engel, Andrew G.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2015-08-01
- Volume
- 72
- Issue
- 8
- Pages
- 889
- ISSN
- 2168-6149 (ISSN-L)
- PMC
- PMC4532561
- OpenAlex
- W1567347505
- Cited by
- 53
- References
- 27
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 12 · 2017: 6 · 2016: 6 · 2015: 1 · 2013: 1
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Japan Society for the Promotion of Science (15H04840)
- National Institute of Neurological Disorders and Stroke (NS-62777, R01NS006277, R56NS006277)
- Topics
- Health Sciences › Medicine › Neurology › Myasthenia Gravis and Thymoma
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics › Neurogenetic and Muscular Disorders Research
- Keywords
- congenital myasthenic syndrome, LRP4, neuromuscular transmission, neuromuscular junction, agrin, musk, acetylcholine receptor, acetylcholinesterase, intercostal muscles, homozygous mutation
- MeSH terms
- Adult, Female, Humans, Mutation, Myasthenia Gravis, Synaptic Transmission, Neuromuscular Junction, Muscle Weakness, Myasthenic Syndromes, Congenital, LDL-Receptor Related Proteins, Young Adult, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
